Virax Biolabs Group Limited (VRAX) Net Income by Year
Virax Biolabs Group Limited reported a net loss of $5.0M in fiscal year 2026. This represents an increase of 17.1% from the prior fiscal year. The table below carries 6 fiscal years, from 2021 to 2026, and the quarters Virax Biolabs Group Limited has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
VRAX Net Income by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
VRAX Net Income by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What net income means
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.
More Virax Biolabs Group Limited financials
Frequently Asked Questions
What was Virax Biolabs Group Limited's net income in fiscal year 2026?
Virax Biolabs Group Limited reported a net loss of $5.0M in fiscal year 2026.
How fast is Virax Biolabs Group Limited's net income growing?
Virax Biolabs Group Limited (VRAX) net income rose by 17.1% year over year, from -$6.1M to -$5.0M in fiscal year 2026.
What does net income mean on a financial statement?
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Virax Biolabs Group Limited (VRAX) reported on that line in every period on record.